News for Healthier Living

Donor Cord Blood Composition May Influence CAR NK Cell Therapy Outcomes

The composition of donor cord blood may play a critical role in the success of chimeric antigen receptor (CAR) natural killer (NK) cell therapies. A small population of immature NK cells present in donor cord blood can undermine the activity of CAR NK cell therapy by redirecting potent immune cells away from tumors and causing them to attack one another, according to researchers from The University of Texas MD Anderson Cancer Center.

July 29, 2026


July 29 2026

July 28 2026

July 27 2026

July 26 2026

July 25 2026

July 24 2026

July 23 2026

July 22 2026

July 21 2026

July 20 2026

July 17 2026

July 16 2026

July 15 2026